Our team of seasoned professionals bring experience from mature North American Cannabis markets, Entrepreneurial ventures, and the European Pharmaceutical industry.
In North America, our COO has produced more than 30 Tons of flower to EU GMP Standards, consulted on the design of more than 200,000m2 of indoor facilities, and has owned/operated a cultivation & processing facility in Washington State for the past six years.
In Europe, our QP & Director of Regulatory Affairs have more than 30 years of combined EU pharmaceutical experience and have both been through the GACP & GMP Inspection & approval process.
We are ideally positioned to compete in a quickly developing and competitive market to both meet the requirements of EU GACP Cultivation, while raising the bar of quality in Europe to match that of the most competitive North American markets.
ELEVATING
STANDARDS
Our team will leverage its established track record in mature cannabis markets across North America, and in the EU Pharmaceutical Industry, to cultivate unique strains with tailored potency.
FOCUSED
APPROACH
Our proprietary & client-tailored approach towards trimming and curing has been designed to serve distribution partners who are focused on high quality rather than high volumes and want to differentiate their products based on strong terpene profiles and meticulously trimmed buds.
We seek to work with small to medium sized distributors who are positioning their products in the premium segment of the EU Cannabis market.